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Abstract: Recent studies using magnetic resonance imaging have suggested that the subchondral bone marrow and the 
entheses are the sites which are primarily involved in the peripheral and axial inflammation found in patients with 
spondyloarthritides. Histopathological analyses indicated that the typical morphological features at these sites reflect an 
inflammation (osteitis) at the bone cartilage interface and in the subchondral bone marrow. This finding implies that 
synovitis may be of minor importance, especially in comparison to other inflammatory joint diseases such as rheumatoid 
arthritis. Here, we summarize current available knowledge on synovial involvement in inflammatory processes related to 
SpA. 
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INTRODUCTION 
  The spondyloarthritides (SpA) comprise ankylosing 
spondylitis (AS), reactive arthritis, arthritis/spondylitis with 
inflammatory bowel disease and arthritis/spondylitis with 
psoriasis. The main link between these diseases is the 
similarity of clinical symptoms such as inflammatory back 
pain, the pattern of peripheral joint involvement with an 
asymmetrical arthritis predominantly of the lower limbs, the 
possible occurrence of sacroiliitis, spondylitis, enthesitis and 
uveitis, and the association with HLA-B27 [1]. The SpA can 
also be split into SpA with predominant axial or predominant 
peripheral involvement, but overlap occurs often, in > 30% 
of the cases. In axial SpA, the disease starts in > 90% with a 
sacroiliitis. Further in the course of AS the whole spine can 
be affected with spondylitis and arthritis of the intervetebral 
joints. The use of magnetic resonance imaging (MRI) 
techniques has been a major step forward in the management 
of patients with axial SpA regarding an earlier diagnosis, and 
for the detection and monitoring of inflammatory activity 
[2]. 
  As a reaction to persistent inflammation with bone 
destruction new bone formation and ankylosis may occur as 
part of a repair mechanism if inflammation has resolved [3, 
4]. Historical studies on the histopathology of inflammation 
in AS already revealed clear evidence that osteitis is the 
primary inflammatory event in AS [5-12]. Although 
published more than 50 years ago, these studies are still 
unique and give readable insights to possible disease 
mechanisms. Compared to all present studies of the nearer 
future entire dead bodies of AS patients with affected axial 
and peripheral joints were studied. In these reports osteitis 
was a predominant finding and synovitis seemed to be of less  
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importance. Additionally, to our knowledge immunohisto-
chemical analysis of spinal synovitis except for sakroiliitis 
has not been undertaken so far. However, immunohisto-
chemical analysis of synovitis in peripheral joint manife-
stations in different forms of SpA has extensively been 
studied by Baeten and collegues [13-16]. 
SYNOVITIS IN ANKYLOSING SPONDYLITIS – 
VERTEBRAL COLUMN 
  Bony tissue samples from facet joints of the lumber spine 
of AS patients who underwent a polysegmental correction of 
rigid hyperkyphosis were collected to further study 
inflammation in the axial skeleton by histopathological and 
immunhistochemical analyses [17]. This study showed that 
facet joints are directly involved in inflammatory processes 
in AS. Inflammation was located in the subchondral bone 
marrow and the enthesis at the articular processes from facet 
joints. Synovitis was not a predominant finding in this and 
other studies [7, 18]. It was striking that even after long 
standing disease duration, inflammatory activity was still 
present in the spine of AS patients with advanced ankylosis. 
The finding that T- and B cells next to high microvessel 
density in lesions with persistent inflammation suggested 
that several immunological mechanisms are involved in the 
pathogenesis of this disease [19]. Interestingly, a very recent 
study on the clinical response of AS patients to B cell 
depleting therapy with rituximab showed clinical 
improvement in TNF blocker naïve AS patients [20]. 
SYNOVITIS IN ANKYLOSING SPONDYLITIS – 
SACROILIAC JOINT 
  At the onset of AS sacroiliac joints of AS patients are 
primarily affected. Within the last decades numerous 
histomorphological descriptions of sacroiliac joints have 
been published while immunohistochemical analyses are 
rare. Inflammation in the subchondral and synovitis are the 
earliest histomorphological changes. In contrast to 
immunohistochemical observations in peripheral joints of   
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rheumatoid arthritis patients the hypertrophic synovia 
displays only little synovial hyperplasia of the synovial layer 
cells and the subsynovial tissue consisted of macrophages 
and T lymphocytes [21-23]. Destruction of cartilage by 
synovitis has been reported as well as loss of synovium if the 
sacroiliac joint is completely ankylosed [8, 11, 22]. It is 
indeed suggestive that destruction of cartilage in sacroiliac 
joints of AS patients is not only caused by subchondral joint 
inflammation but also by synovitis. Immunhistochemical 
analysis and in situ hybridisation revealed that mononuclear 
cell infiltrates and TNF might be important mediators 
during inflammatory processes in the subchondral bone of 
affected joints [21, 23]. 
SYNOVITIS IN DIFFERENT SPONDYLOARTHRI-
TIDES – HIP ARTHRITIS 
  Historical studies on the histopathological findings in AS 
hip arthritis relied on case reports. However, some of them 
already gave interesting insights into the mechanisms 
involved during inflammatory processes. Bywaters studied 
the body of a 21 year old man who died due to fatal 
secondary amyloidosis [8]. This allowed the unique 
opportunity to study histopathological features in AS. The 
hip joint showed chronic inflammatory changes in the 
synovial membrane. However, these were mild and inactive 
with increased vessel density as reported by others in the 
synovial membrane of AS patients [24]. Only marginal 
cartilage erosion was observed at the surface. Interestingly, 
cellular infiltrates penetrating the bone end plate were mostly 
involved in cartilage destruction from below. More recent 
immunohistochemical analyses characterized the cellular 
components of acute inflammatory lesions in femoral heads 
of AS patients [19, 25]. Enthesial site of femoral heads and 
knees from AS patients undergoing endoprothetic surgery 
displayed inflammation driven by mononuclear cells 
consisting of CD4+ and CD8+ T cells [25]. In the 
subchondral bone marrow and at the bone cartilage interface 
of femoral heads of AS patients the number of subchondral T 
cells was significantly higher in areas with cartilage still on 
the surface compared to areas without cartilage while, in 
contrast, such a difference was not found in RA patients 
[19]. The importance of cellular changes in the bone marrow 
was highlighted by Francois and colleagues [22]. 
Angiogenesis as measured by microvessel density was 
significantly increased in AS patients compared to RA and 
OA. The number of osteoclastic foci in areas of bone 
resorption at the bone cartilage interface of femoral heads 
with cartilage on the surface was also significantly higher in 
AS compared to RA and OA [19]. In these samples some 
femoral heads had adjacent synovial membranes for further 
analysis which only revealed minor acute inflammatory 
lesions compared to the subchondral bone marrow (Appel, 
unpublished data). This was also a major difference in 
comparison to RA femoral heads. Thus, a very important 
conclusion from this study was that inflammation is primary 
located in the subchondral bone marrow and not in the 
synovial membrane. Furthermore, inflammation seems to be 
linked to the presence of cartilage and disappears once 
cartilage is destroyed. This concept is further supported by 
the use of MRI for the investigation of acute inflammation in 
AS. Several studies consistently reported subchondral bone  
 
marrow oedema as the primary site of inflammation and as a 
consequence of inflammation at different sites such as 
sacroiliac joints [23], femoral head [26], manubriosternal 
joints [27]. 
SYNOVITIS IN DIFFERENT SPONDYLOARTHRI-
TIDES – PERIPHERAL JOINTS AND JOINTS FROM 
THE ANTERIOR CHEST WALL 
  Most of the histomorphological descriptions discussing 
synovitis in AS are historical reports [5, 7, 18, 28]. Only few 
groups have undertaken systematic analysis of peripheral 
joints in SpA administrating immunohistochemical analysis 
[13-15, 29-35]. Increased mononuclear cell infiltration and 
increased vascularity were frequently observed if patients 
with SpA and rheumatoid arthritis were compared. In SpA 
synovitis lymphocytic infiltrates consisting of CD3+, CD4+ 
and CD20+ cells [13] and plasma cells [29] were observed. 
Single cell analysis and the quantification of lymphocytic 
aggregates revealed lower frequencies of CD4+ and CD20+ 
lymphocytes than in RA synovium. Interestingly, this was 
not the case for CD8+ T cells. Studies before and during 
TNF blocker therapy revealed evidence that TNF is an 
important pro-inflammatory cytokine also for peripheral 
joint inflammation in SpA. Mononuclear cell infiltrates 
decreased significantly during therapy [14]. Interestingly, T 
cell but not B cell infiltrates resolved during TNFalpha 
blocker treatment suggesting that T-cell types are important 
mediators of inflammation in SpA synovitis. Specific 
macrophage subsets like M2 macrophages and also 
polymorphonuclear cells are also seen in SpA synovitis [30]. 
These cellular components correlate well with global disease 
activity and decrease rapidly during successful treatment 
with TNFalpha blocking agents [14, 31]. Because Toll like 
receptors were also increased in active SpA synovitis it has 
been hypothesized that inflammation triggered by the innate 
immune system is also involved in the pathogenesis of SpA 
synovitis [16, 36]. Especially hypervascularity and the 
presence of tortuous vessels were identified as a typical 
feature in SpA which was also observed by others [24, 34] 
but not in RA. In summary, these studies revealed some 
evidence that neovascularization might be a more important 
mechanism in SpA compared to RA and therefore also a 
possible therapeutic target. We do not know of any 
immunohistochemical analysis of SpA patients comparing 
osteitis and synovitis in peripheral joints. However, 
peripheral arthritis in the knee seemed be driven by 
inflammation in the synovial membrane which is also 
supported by MRI [37]. 
  Engfeldt and colleagues had studied an acromio-
clavicular joint in an AS patient. Beside features of new 
bone formation they could also describe synovitis in the 
adjacent soft tissue with mononuclear cell aggregates and 
high vascularity [5]. This was accompanied by inflammation 
in the bone marrow, bone edema and bone destruction. 
Cruickshank studied additional samples from the anterior 
chest wall. The earliest changes in the manubriosternal joints 
were also a subacute osteitis in the subchondral bone marrow 
underneath the bone end plate. This consisted of 
inflammatory cell infiltrates and fibrous tissue with 
increased microvessel density. 
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SUMMARY 
  Histopathological analysis of joint inflammation in 
patients with AS or other SpA provide some evidence that 
joint inflammation within the axial skeleton and the chest 
wall as well as in the hip is mostly driven by inflammation in 
the bone marrow either at the enthesial site or in the 
subchondral bone marrow. Peripheral arthritis in the knee 
seemed be driven by inflammation in the synovial 
membrane, this is also supported by MRI. 
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